LOS ANGELES, Feb. 6, 2004 (PRIMEZONE) -- Tec Factory, Inc. (Pink Sheets:TECF), today announced that it has acquired 100% of issued and outstanding shares of HeartSTAT, Inc., which is in the process of bringing to market the first practical system for monitoring blood flow perfusion (oxygen transport) and important heart dynamics. It is noninvasive, continuous, and uses a simple comfortable disposable sensor. This addresses key issues of hospital critical care.
-- Blood pressure (BP) and pulse oximeter (POX) devices are the
means of preventive monitoring and managing cardiovascular
disease. However, these are commonly misleading and slow to
reflect abnormality, often until it is too late.
-- Present cardiac output measurement is restricted to the most
critical procedures on about only 5% of patients because of
risks and costs.
-- Blood flow and perfusion are early and more specific indications
for managing vital patient risks; yet this monitoring has not
been practical.
The Company's FDA-cleared CNBP system was recently cost re-engineered to be the first price competitive continuous system for upgrading a market of over a million units. HeartSTAT recently enhanced this technology to include a single-patient use sensor for an optional CNBP "platform" for upgrading users to blood flow perfusion monitoring without the delay of capital budgeting.
By combining its CNBP sensing functions with its breakthrough blood flow perfusion technology, the Company intends to establish a new healthcare standard. It is preparing to commence CNBP product shipments within a year and shipments of blood flow monitors six months later.
Executives at major firms have advised that negotiations would be proposed as soon as the HeartSTAT blood flow perfusion system is marketed. Revenues of $200 million are projected, representing a 10% market share. Management believes exit opportunities will exist within three years that should yield an ROI well in excess of 35% annually.
Tec Factory, Inc will immediately amend its name to HeartSTAT Technology, Inc. and apply for a new trading symbol from the NASD and file its Form 10SB with the SEC to become a full reporting company. Once fully reporting HeartSTAT plans to apply for trading on the OTCBB, AMEX or Nasdaq exchange.
More information can be found at www.eAngels.com/HeartStat.
Statements in this release are made pursuant to the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties including, without limitation, continued acceptance of the Company's services, increased levels of competition for the Company and dependence on the performance of the Management of the Company.